Miranda-Verastegui, C., Tulliano, G., Gyorkos, T. W., Calderon, W., Rahme, E., Ward, B., . . . Matlashewski, G. (2009). First-line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony. Public Library of Science (PLoS).
Cita Chicago Style (17a ed.)Miranda-Verastegui, Cesar, Gianfranco Tulliano, Theresa W. Gyorkos, Wessmark Calderon, Elham Rahme, Brian Ward, Maria Cruz, Alejandro Llanos-Cuentas, y Greg Matlashewski. First-line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony. Public Library of Science (PLoS), 2009.
Cita MLA (8a ed.)Miranda-Verastegui, Cesar, et al. First-line Therapy for Human Cutaneous Leishmaniasis in Peru Using the TLR7 Agonist Imiquimod in Combination with Pentavalent Antimony. Public Library of Science (PLoS), 2009.